COCP Cocrystal Pharma, Inc. - Common Stock
$1,08
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$1–$3
17% of range
Analystenbewertung
BUY
7 analysts
Kursziel
$9
+733% upside
P/E (TTM)
-1.4
ROE
-151.4%
Nettogewinnmarge
—
COCP Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.08
Marktkapitalisierung
$15M
P/E (TTM)
-1.4
EPS (TTM)
$-0.78
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-151.4%
Verschuldungsgrad
—
52W-Spanne
$1 – $3
COCP Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2019-12-31
→
2020-12-31
EPS
$-0.78
2016-12-31
→
2025-12-31
Freier Cashflow
$-8M
2018-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
COCP
Peer-Median
P/E (TTM)
-1.4
44.2
P/S (TTM) (K/V (TTM))
7.5
8.2
P/B (K/B)
2.4
2.1
Price / FCF (Kurs / FCF)
-1.8
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
COCP
Peer-Median
ROA
-76.2%
-49.9%
ROE
-151.4%
-51.4%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
COCP
Peer-Median
Current Ratio (Liquiditätsgrad)
3.7
3.7
Quick Ratio
3.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
COCP
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
COCP
Peer-Median
COCP Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
7 Analysten
- Starker Kauf 2 28,6%
- Kauf 4 57,1%
- Halten 1 14,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
2 Analysten · 2026-08-18
Median
$9.00
← Unter allen Zielen
$1.08
Tief
$8.00
Hoch
$10.00
Median-Ziel
$9.00
+733,3%
Mittelwert-Ziel
$9.00
+733,3%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.10%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.17 | $-0.15 | -0.02% |
| 31. Dezember 2025 | $-0.17 | $-0.18 | 0.01% |
| 30. September 2025 | $-0.19 | $-0.21 | 0.02% |
| 30. Juni 2025 | $-0.20 | $-0.31 | 0.11% |
| 31. März 2025 | $-0.23 | $-0.52 | 0.29% |
| 31. Dezember 2024 | $-0.32 | $-0.54 | 0.22% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| COCP | $14M | -1.3 | — | — | -151.4% | — |
| TVRD | $40M | -1.3 | -66.0% | — | -67.6% | — |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | — |
| BFRI | — | — | — | — | — | — |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | — |
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| TRAW | — | 1.4 | 1134.5% | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $2M | $7M | · | · | · | · | · | |
| R&D Expense | $5M | $13M | $15M | $12M | $9M | $6M | $4M | $5M | $6M | $102M | $47M | $4M | |
| SG&A Expense | $4M | $5M | $6M | $6M | $5M | $6M | $5M | $4M | $2M | $4M | $7M | $2M | |
| Operating Expenses | $9M | $18M | $19M | $39M | $14M | $12M | $55M | $63M | $8M | $106M | $54M | $6M | |
| Operating Income | $-9M | $-18M | $-19M | $-39M | $-14M | $-10M | $-48M | $-63M | $-8M | $-106M | $-54M | $-6M | |
| Interest Expense | · | · | $-640.0K | $2.0K | $4.0K | $8.0K | $19.0K | $58.0K | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | $-7.0K | $126.0K | $180.0K | $96.0K | |
| Other Non-op | $188.0K | $374.0K | $575.0K | $-8.0K | $36.0K | $-62.0K | $237.0K | $294.0K | $769.0K | $2M | $-11M | $6M | |
| Pretax Income | $-9M | $-19M | · | · | · | $-10M | $-48M | $-63M | $-7M | $-104M | $-65M | $-151.0K | |
| Income Tax | · | · | · | · | · | · | · | $-14M | $-7M | $-29M | $-15M | $-52.0K | |
| Net Income | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| EPS (Basic) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | $-0.16 | · | · | · | $-0.03 | $-3.18 | $-2.40 | $0.00 | |
| EPS (Diluted) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · | · | · | · | $-0.03 | $-3.30 | $-2.40 | $-0.01 | |
| Shares (Basic) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | 7,364,000 | · | 31,859 | 28,009 | 24,126,000 | 23,518,000 | 21,011,000 | 326,779,000 | |
| Shares (Diluted) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | · | · | · | · | 24,126,000 | 23,533,000 | 21,011,000 | 327,753,000 | |
| EBITDA | $-9M | $-18M | · | $-39M | $-14M | $-10M | $-48M | $-63M | · | · | · | · |
Bilanz 24
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $26M | $37M | $59M | $33M | $7M | $3M | $748.0K | $4M | $9M | $4M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Receivables | · | · | · | · | · | $556.0K | $644.0K | · | $1.0K | $21.0K | $32.0K | $122.0K | |
| Prepaid Expense | $328.0K | $430.0K | $2M | $2M | $568.0K | $399.0K | $169.0K | $191.0K | $105.0K | $517.0K | $441.0K | $144.0K | |
| Current Assets | $8M | $12M | $29M | $40M | $59M | $34M | $8M | $3M | $2M | $5M | $10M | $6M | |
| PP&E (Net) | $93.0K | $153.0K | $271.0K | $342.0K | $453.0K | $591.0K | $431.0K | $384.0K | $119.0K | $280.0K | $430.0K | $284.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $983.0K | $1M | $1M | $1M | $949.0K | |
| Goodwill | · | · | · | · | $19M | $19M | $19M | $65M | $65M | $65M | $65M | $65M | |
| Total Assets | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Accounts Payable | $890.0K | $2M | $1M | $614.0K | $578.0K | $657.0K | $2M | $616.0K | $494.0K | $563.0K | · | $299.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $563.0K | $3M | $693.0K | |
| Current Liabilities | $2M | $2M | $3M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $7M | $9M | |
| Capital Leases | $1M | $2M | $2M | $57.0K | $291.0K | $345.0K | $523.0K | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $14M | $20M | $50M | $65M | |
| Total Liabilities | $3M | $4M | $5M | $1M | $2M | $2M | $3M | $2M | $16M | $23M | $57M | $74M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $50M | $65M | |
| Common Stock | $13.0K | $10.0K | $10.0K | $8.0K | $8.0K | $71.0K | $36.0K | $30.0K | $24.0K | $24.0K | $694.0K | $123.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $243M | $240M | $229M | $19M | |
| Retained Earnings | $-342M | $-333M | $-316M | $-298M | $-259M | $-245M | $-235M | $-187M | $-138M | $-137M | $-63M | $-12M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $0 | $236.0K | |
| Stockholders' Equity | $6M | $10M | $26M | $40M | $78M | $53M | $26M | $67M | $105M | $102M | $168M | $7M | |
| Liabilities + Equity | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Shares Outstanding | 13,784,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 70,439,000 | 35,150,000 | 29,938,000 | 24,275,000 | 23,801,000 | 694,396,000 | 122,494 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $72.0K | $126.0K | $189.0K | $185.0K | $190.0K | $157.0K | $98.0K | $6.0K | $101.0K | $201.0K | $192.0K | $199.0K | |
| Stock-based Comp | $270.0K | $643.0K | $801.0K | $855.0K | $724.0K | $662.0K | $351.0K | $562.0K | $614.0K | $548.0K | $3M | $38.0K | |
| Deferred Tax | · | · | · | · | · | · | $-14M | $-14M | $-7M | $-29M | $-15M | $-54.0K | |
| Operating Cash Flow | $-8M | $-16M | $-15M | $-21M | $-13M | $-10M | $-2M | $-8M | $-7M | $-15M | $-10M | $-6M | |
| CapEx | $12.0K | $8.0K | $118.0K | $74.0K | $52.0K | $240.0K | $145.0K | $28.0K | $40.0K | $51.0K | $339.0K | $5.0K | |
| Investing Cash Flow | $-12.0K | $-8.0K | $-118.0K | $-74.0K | $-52.0K | $-240.0K | $-145.0K | $1M | $-40.0K | $3.0K | $-262.0K | $6M | |
| Stock Issued | $154.0K | · | $4M | · | $39M | $36M | $7M | $8M | $3M | $9M | $16M | · | |
| Net Stock Activity | $154.0K | · | · | · | $39M | $36M | $7M | $8M | · | · | · | · | |
| Financing Cash Flow | $5M | · | $4M | $-27.0K | $38M | $36M | $6M | $9M | $4M | $9M | $16M | $3M | |
| Net Change in Cash | $-3M | $-16M | $-11M | $-22M | $26M | $26M | $5M | $2M | $-3M | $-6M | $5M | $3M | |
| Free Cash Flow | $-8M | $-16M | · | $-22M | $-13M | $-10M | $-2M | $-8M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | $-8M | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| Net Margin | · | · | · | · | · | -479.0% | -733.8% | 84565.5% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | -479.0% | -733.8% | 107982.8% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| ROA | -76.2% | -78.3% | · | -64.6% | -21.2% | -23.3% | -99.2% | -51.6% | · | · | · | · | |
| ROE | -151.4% | -157.5% | · | -86.8% | -17.9% | -18.8% | -99.9% | -55.2% | · | · | · | · | |
| ROIC | · | · | · | · | · | · | · | -73.7% | · | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.8 | · | 33.0 | 38.4 | 25.0 | 3.6 | 1.9 | · | · | · | · | |
| Quick Ratio | 3.2 | 4.1 | · | 30.6 | 38.0 | 24.7 | 3.5 | 1.7 | · | · | · | · | |
| Interest Coverage | · | · | · | -19414.5 | -3555.2 | -1198.2 | · | -1084.9 | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.1 | -0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | 3.4 | 20.4 | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | $7M | $78.0K | $78.0K | $78.0K | · | · | |
| Net Income TTM | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| Market Cap | $14M | $21M | · | $16M | $760M | $1.15B | $211M | $1.29B | · | · | · | · | |
| P/E | -1.3 | -1.2 | -0.9 | -0.4 | · | · | -85.7 | 1440.0 | -2400.0 | -42.5 | -133.5 | -15120.0 | |
| P/S | 6.8 | 10.3 | · | 8.0 | 380.9 | 570.8 | 32.1 | 16581.0 | · | · | · | · | |
| P/B | 2.1 | 2.2 | · | 0.4 | 9.8 | 21.9 | 8.2 | 19.3 | · | · | · | · | |
| P / Tangible Book | 2.1 | 2.2 | 0.7 | 0.4 | 13.0 | 34.4 | · | · | · | · | · | · | |
| P / Cash Flow | -1.6 | -1.2 | · | -0.7 | -59.8 | -116.9 | -134.9 | -156.0 | · | · | · | · | |
| P / FCF | -1.6 | -1.2 | · | -0.7 | -59.5 | -114.2 | -123.5 | -155.5 | · | · | · | · | |
| Earnings Yield | -79.6% | -85.2% | -108.7% | -244.6% | · | · | -1.2% | 0.07% | -0.04% | -2.4% | -0.75% | -0.01% |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $105.0K | $225.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $2M | $1M | $2M | $954.0K | $1M | $1M | $2M | $3M | $4M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | |
| SG&A Expense | $1M | $1M | $862.0K | $1M | $986.0K | $981.0K | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | |
| Operating Expenses | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $5M | $5M | $4M | $5M | $4M | $4M | $5M | $5M | $6M | |
| Operating Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $-220.0K | · | $-320.0K | $-140.0K | · | $0 | $1.0K | |
| Other Non-op | $20.0K | $57.0K | $55.0K | $40.0K | $53.0K | $40.0K | $-36.0K | $103.0K | $105.0K | $202.0K | $202.0K | $278.0K | $173.0K | $-78.0K | $1.0K | $-6.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| EPS (Basic) | $-0.23 | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | $-0.70 | |
| EPS (Diluted) | $-0.23 | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.54 | $-0.70 | |
| Shares (Basic) | 13,788,000 | 13,786,000 | -20,049,000 | 10,991,000 | 10,174,000 | 10,174,000 | -20,348,000 | 10,174,000 | 10,174,000 | 10,174,000 | -18,710,000 | 10,153,000 | 10,065,000 | 8,143,000 | -16,286,000 | 8,143,000 | |
| Shares (Diluted) | 13,788,000 | 13,786,000 | -20,049,000 | 10,991,000 | 10,174,000 | 10,174,000 | -20,348,000 | 10,174,000 | 10,174,000 | 10,174,000 | -18,710,000 | 10,153,000 | 10,065,000 | 8,143,000 | 0 | 8,143,000 | |
| EBITDA | $-3M | $-2M | · | $-2M | $-2M | $-2M | · | $-5M | $-5M | $-4M | · | $-4M | $-4M | $-5M | · | $-6M |
Bilanz 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $7M | $8M | $5M | $7M | $10M | $13M | $18M | $22M | $26M | $30M | $32M | $34M | $37M | $42M | |
| Prepaid Expense | $256.0K | $418.0K | $328.0K | $465.0K | $282.0K | $385.0K | $430.0K | $509.0K | $365.0K | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Current Assets | $3M | $6M | $8M | $9M | $7M | $9M | $12M | $14M | $20M | $24M | $29M | $32M | $36M | $37M | $40M | $45M | |
| PP&E (Net) | $69.0K | $81.0K | $93.0K | $106.0K | $107.0K | $127.0K | $153.0K | $181.0K | $211.0K | $244.0K | $271.0K | $252.0K | $305.0K | $338.0K | $342.0K | $378.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | $2M | |
| Total Assets | $5M | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | |
| Accounts Payable | $2M | $1M | $890.0K | $745.0K | $856.0K | $808.0K | $2M | $859.0K | $2M | $1M | $1M | $568.0K | $1M | $3M | $614.0K | $897.0K | |
| Current Liabilities | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $1M | $2M | |
| Capital Leases | $989.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | · | $10.0K | $27.0K | $57.0K | $119.0K | |
| Total Liabilities | $4M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $2M | $2M | $3M | $1M | $2M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $8.0K | $8.0K | |
| Retained Earnings | $-348M | $-345M | $-342M | $-340M | $-338M | $-336M | $-333M | $-330M | $-325M | $-320M | $-316M | $-311M | $-307M | $-303M | $-298M | $-293M | |
| Stockholders' Equity | $1M | $4M | $6M | $8M | $5M | $7M | $10M | $13M | $17M | $23M | $26M | $31M | $35M | $35M | $40M | $44M | |
| Liabilities + Equity | $5M | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | |
| Shares Outstanding | 13,789,000 | 13,787,000 | 13,784,000 | 13,041,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 8,143,000 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12.0K | $12.0K | $13.0K | $13.0K | $21.0K | $25.0K | $28.0K | $30.0K | $33.0K | $35.0K | $40.0K | $53.0K | $47.0K | $49.0K | $48.0K | $47.0K | |
| Stock-based Comp | $92.0K | $84.0K | $56.0K | $48.0K | $84.0K | $82.0K | $85.0K | $253.0K | $148.0K | $157.0K | $158.0K | $173.0K | $179.0K | $291.0K | $159.0K | $216.0K | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-1M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-6M | $-3M | $-5M | $-9M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | $0 | $8.0K | $59.0K | $0 | $14.0K | $45.0K | $12.0K | · | |
| Investing Cash Flow | · | · | $0 | · | · | · | $0 | $0 | $0 | $-8.0K | $-59.0K | $0 | $-14.0K | $-45.0K | $-12.0K | · | |
| Stock Issued | · | · | $0 | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | · | · | $1M | · | · | · | · | · | · | · | $0 | $0 | $4M | $-7.0K | $-7.0K | $-7.0K | |
| Net Change in Cash | $-3M | $-2M | $-704.0K | $3M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-2M | $-3M | $-5M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-3M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3032.4% | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -3013.3% | -1021.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -3032.4% | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -48.1% | -25.4% | · | -15.4% | -13.7% | -12.4% | · | -20.2% | -18.5% | -12.3% | · | -10.6% | -9.4% | -9.2% | · | -8.9% | |
| ROE | -99.2% | -40.3% | · | -20.1% | -18.1% | -15.4% | · | -22.8% | -20.5% | -13.8% | · | -11.2% | -9.9% | -9.6% | · | -9.1% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.7 | · | 5.8 | 3.7 | 4.6 | · | 7.3 | 7.4 | 10.3 | · | 16.7 | 22.5 | 11.8 | · | 27.7 | |
| Quick Ratio | 0.8 | 2.1 | · | 5.1 | 2.6 | 3.6 | · | 6.7 | 6.8 | 9.2 | · | 15.5 | 20.4 | 10.8 | · | 26.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 18.9 | · | 13.9 | 31.0 | · | · | -5694.0 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-10M | $-9M | · | $-11M | $-15M | $-17M | · | $-18M | $-18M | $-17M | · | $-19M | $-39M | $-40M | · | $-38M | |
| Market Cap | $14M | $14M | · | $16M | $15M | $14M | · | $18M | $24M | $14M | · | $19M | $24M | $16M | · | $28M | |
| P/E | -1.3 | -1.3 | · | -1.1 | -1.0 | -0.9 | · | -1.0 | -1.3 | -0.8 | · | -0.9 | -0.5 | · | · | · | |
| P/S | · | · | · | 8.2 | 7.6 | 7.2 | · | 9.0 | 11.9 | 7.1 | · | 9.5 | 12.2 | 8.1 | · | 14.2 | |
| P/B | 13.9 | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | 0.7 | 0.5 | · | 0.6 | |
| P / Tangible Book | 13.9 | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | 0.7 | 0.5 | · | 0.6 | |
| P / Cash Flow | · | -6.0 | · | · | · | -4.9 | · | · | · | -3.2 | · | · | · | -5.2 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -3.2 | · | · | · | -5.1 | · | · | |
| Earnings Yield | -75.2% | -78.2% | · | -88.8% | -97.3% | -115.5% | · | -103.4% | -74.7% | -132.1% | · | -115.5% | -198.7% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-9M | $-18M | $-18M | $-39M | $-14M |
| Verwässerte EPS | $-0.78 | $-1.72 | $-1.87 | $-4.77 | — |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.7 | 4.8 | — | 33.0 | 38.4 |
| Quick Ratio | 3.2 | 4.1 | — | 30.6 | 38.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-8M | $-16M | — | $-22M | $-13M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 28 Einreicher · $1.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 8 (+6 vs. Vorquartal) | 6 (+3 vs. Vorquartal) | 2 (-3 vs. Vorquartal) | 7 (+2 vs. Vorquartal) | +604K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $376.139 | 358.228 | 32,52% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $188.609 | 179.628 | 16,31% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $184.148 | 175.379 | 15,92% | Aktien |
| BlackRock, Inc. | $77.433 | 73.746 | 6,70% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $74.175 | 70.628 | 6,41% | Aktien |
| CITADEL ADVISORS LLC | $47.374 | 45.118 | 4,10% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $33.480 | 31.886 | 2,89% | Aktien |
| XTX Topco Ltd | $30.809 | 29.342 | 2,66% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $25.217 | 24.016 | 2,18% | Aktien |
| JANE STREET GROUP, LLC | $23.777 | 22.645 | 2,06% | Aktien |
| VANGUARD GROUP INC | $23.512 | 24.016 | 2,03% | Aktien |
| STATE STREET CORP | $21.570 | 20.543 | 1,87% | Aktien |
| Parallel Advisors, LLC | $13.197 | 12.569 | 1,14% | Aktien |
| NORTHERN TRUST CORP | $12.517 | 11.921 | 1,08% | Aktien |
| Ground Swell Capital, LLC | $11.290 | 10.752 | 0,98% | Aktien |
| WELLS FARGO & COMPANY/MN | $6.564 | 6.251 | 0,57% | Aktien |
| Tower Research Capital LLC (TRC) | $4.183 | 3.984 | 0,36% | Aktien |
| MORGAN STANLEY | $915 | 871 | 0,08% | Aktien |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $858 | 817 | 0,07% | Aktien |
| Clean Yield Group | $439 | 418 | 0,04% | Aktien |
| UBS Group AG | $125 | 119 | 0,01% | Aktien |
| NVWM, LLC | $88 | 84 | 0,01% | Aktien |
| BARCLAYS PLC | $44 | 42 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $35 | 33 | 0,00% | Aktien |
| HRT FINANCIAL LP | $21 | 20.336 | 0,00% | Aktien |
| VIMA LLC | $18 | 17 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $0 | 9 | 0,00% | Aktien |
| Motiv8 Investments LLC | $0 | 42 | 0,00% | Aktien |
Unternehmensinsider 2 Insider · 0 Führungskräfte · 0 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Phillip Frost, M.D. | — | 5. August 2026 P | 1.993.551 | 2 | 0 | $80.300 |
| James Sapirstein | — | 3. Juni 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Phillip Frost, M.D., Frost Gamma Investments Trust ×6 Einreichungen | 7. August 2026 | 13,90% | Änderung | — | SEC |
| OPKO HEALTH, INC., FROST PHILLIP MD ET AL, Frost Gamma Investments Trust, Rubin Steven D ×5 Einreichungen | 7. August 2026 | 29,60% | Erste Einreichung | Passive Anlage | SEC |
| FiveT Investment Management Ltd, FiveT Capital AG | 25. Mai 2021 | — | Erste Einreichung | — | SEC |
| Raymond F. Schinazi, Phillip Frost, M.D., Frost Gamma Investments Trust, Gary Wilcox, Roger Kornberg, Steven D. Rubin ×3 Einreichungen | 19. März 2019 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.